Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from COMPASS Pathways, Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups
Investigator-initiated study shows remission in major depression symptoms for 50% of participants London, UK 20 October 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients. Within one week of a single ...
Investegate announcements from Clarify Pharma PLC, Clarify Pharma Makes First Capital Investment
Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021 Partnership being developed with
Press release content from Globe Newswire. The AP news staff was not involved in its creation.